Helix BioPharma announces Q2 2006 financial results (Chronic Hepatitis C)

Helix BioPharma announces Q2 2006 financial results
[Press Release] CNW Group via Yahoo! Finance - Mar 14 2:00 PM
Helix BioPharma Corp. today announced financial results for the second quarter of fiscal 2006, ended January 31, 2006.Save to My Web

Human Genome Sciences Reports Positive Interim Results of Phase 2 Trial of Albuferon(TM) In Combination With Ribavirin
[Press Release] PR Newswire via Yahoo! Finance - Mar 14 5:01 AM
Human Genome Sciences, Inc. today reported the interim results of a Phase 2 clinical trial to evaluate the safety, tolerability and efficacy of Albuferon in combination with ribavirin in patients with chronic hepatitis C who failed to respond to previous interferon alpha-based treatment regimens.Save to My Web

SciClone's ZADAXIN Granted Orphan Drug Designation for Malignant Melanoma in United States
SYS-CON Media - Mar 20 8:29 AM
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN)today announced that thymalfasin, the chemical composition of ZADAXIN ,has been granted Orphan Drug designation for the treatment of stage IIbthrough stage IV malignant melanoma by the U.S. Food and DrugAdministration (FDA). Orphan Drug designation could provide SciClone withseven years of market exclusivity in the United States should ZADAXINreceive Save to My Web

Advanced Biotherapy Signs Memorandum of Understanding with Battelle
[Press Release] Business Wire via Yahoo! Finance - Mar 22 6:30 AM
WOODLAND HILLS, Calif.----March 22, 2006--Advanced Biotherapy, Inc. today announced that it has entered into an initial Memorandum of Understanding with Battelle for the development and use of monoclonal antibodies to treat humans and animals exposed to anthrax and plague as well as autoimmune diseases.Save to My Web

Metabasis Comments on Positive 48 Week HBV Data From Pradefovir Mesylate Phase 2 Study Reported by Valeant
[Press Release] PR Newswire via Yahoo! Finance - Mar 16 5:45 AM
Metabasis Therapeutics Inc. commented today on the 48 week results from a Phase 2 study of pradefovir, an oral anti-viral product candidate it discovered and subsequently licensed to Valeant Pharmaceuticals International.Save to My Web

Daily Planner: Monday (Chronic Hepatitis C)

Daily Planner: Monday
Chico Enterprise-Record - BLOOD DRIVE: Donor hours 8 a.m.-1 p.m. Saturday; 8 a.m.-3 p.m. Monday and Wednesday; 11 a.m.-6 p.m. Tuesday and Thursday; 7 a.m.-2 p.m. Friday. BloodSource, 555 Rio Lindo Ave., Chico. 893-5433. Weekly. BUTTE COUNTY COORDINATING COUNCIL: 11:15 a.m.-1

Coffee and Me
Sacramento Union - ane called President Nixon a warmonger for sending U.S. troops against the Vietnamese in their sanctuary of Cambodia. Nixon replied that Fonda and kind were a bunch of bums. At a Washington rally Fonda welcomed her fellow bums

Novartis Seen 'Saving Face' With Idenix Hep C Deal
Forbes - Friedman, Billings, Ramsey reiterated an "outperform" rating on Idenix Pharmaceuticals after Swiss pharmaceutical titan Novartis exercised an option to co-develop the biotech firm's lead drug candidate. Novartis (nyse: NVS - news - people ) will pay

Cuban Combined Therapy Against Chronic Hepatitis C (Chronic Hepatitis C)

Cuban Combined Therapy Against Chronic Hepatitis C
Ahora.cu, Cuba - Mar 23, 2006A Cuban combination therapy for the treatment of chronic Hepatitis C is to be put on the market by the Heber Biotec SA company in Latin America, Asia, Africa ...

Talc Retinopathy
New England Journal of Medicine (subscription), MA - Mar 22, 2006A 37-year-old woman with chronic hepatitis C presented with blurred vision after losing her eyeglasses. Her corrected visual acuity was 20/30 in both eyes. ...

Novelos seeks permission to test hepatitis drug in US
Pharmaceutical Business Review - Mar 24, 2006Biotech firm Novelos Therapeutics has filed an investigational new drug application with the FDA for its experimental chronic hepatitis C treatment, NOV-205. ...

Coley Pharmaceutical Group Announces Top-line Data from a Clinical ...
PharmaLive.com (press release), PA - Mar 21, 2006... clinical study of Actilon(TM) (CPG 10101) in combinations with pegylated interferon and/or ribavirin for the treatment of chronic Hepatitis C virus (HCV) in ...

China drugs firm Phynova rallies
ShareCast, UK - Feb 27, 2006... Phynova is currently developing six drug candidates, one for relief of the symptoms of chronic hepatitis C, one for the hepatitis virus, and others for obesity ...

Most chronic hepatitis C sufferers will develop cirrhosis in later (Chronic Hepatitis C)

Most chronic hepatitis C sufferers will develop cirrhosis in later
Nearly 80 percent of chronic hepatitis C sufferers who have the disease for several decades will develop cirrhosis or end-stage liver disease later in life, according to a study published today in the

IDEAL Study - Hepatitis c Clinical Study for patients with chronic hep
This study will begin recruiting chronic hepatitis C patients in January 2004. The IDEAL study is a major clinical study involving 2,880 patients at up to 100 U.S. study centers that has two purposes

Chronic Hepatitis C
Chronic Hepatitis C The hepatitis C virus (HCV) is one of the most important causes of chronic liver disease in the United States.

HCV-Home Ownership Programs (Chronic Hepatitis C)

HCV-Home Ownership Programs
Housing Choice Voucher (Section 8) HUD issued a final rule on 10-12-00 for the For more details click here: HCV Home Buying

HCV database home page
About this database The Hepatitis C Virus (HCV) database project is funded by the Division of Microbiology and Infectious Diseases of the National Institute of Allergies and Infectious Diseases

HCV Wireless
HCV Professional Services HCV Wireless Consulting, Systems Integration and Support Services The primary goal for HCV Wireless Professional Services is to support organisations to rapidly and effectively

Hepatitis C: Tattoo | CDC Viral Hepatitis (Chronic Hepatitis C)

Hepatitis C: Tattoo | CDC Viral Hepatitis
CDC's Position on Tattooing and HCV Infection. Although some studies have found an association between tattooing and HCV infection in very selected ...

Hepatitis C Virus Infection: BC HealthFile #40a
Symptoms of acute hepatitis C infection may include fever, tiredness, jaundice (yellow ... People at higher risk of having hepatitis C infection include: ...

Hepatitis C: An Epidemic for Anyone
Hepatitis C infection is typically mild in its early stages, and it is rarely recognized until it has caused significant damage to the liver. ...

Hepatitis C Virus Lives In Your Liver(NC)-Your liver (Chronic Hepatitis C)

Hepatitis C Virus Lives In Your Liver

(NC)-Your liver works 24 hours a day, performing over 500 vital functions for your body. Most of the blood that returns to your heart passes through the liver. Your body can't function without it.

The hepatitis C virus lives in your liver. It inflames liver cells, which, over time, affects the way your liver functions. The effect of the hepatitis C virus varies from person to person. There is no way to predict how your body will react to it. There are, however, some things that are known:

You can live with hepatitis C for many years without experiencing any major symptoms, or you might simply feel tired. Symptoms can come and go over time. Their presence or absence does not tell you the degree to which liver damage may or may not be occurring. p>

Chronic, long-term inflammation of the liver can cause liver cell damage and result in fibrosis (liver scarring), or even cirrhosis. This damage can occur in as little as five years, or as long as 30 years.

About 20% of chronic hepatitis patients develop cirrhosis within 10 to 20 years.

Use of recreational drugs or alcohol can speed up inflammation and the development of fibrosis or cirrhosis.

There is an increased risk of liver cancer in people with cirrhosis.

The good news is that current drug treatments can be very effective for people with hepatitis C. Combined with proper nutrition, plenty of rest, and avoidance of recreational drugs and alcohol, these treatments help many who have the virus lead relatively healthy lives.

If you think you may be at risk of getting hepatitis C, see your doctor. The virus can be detected by a simple blood test. For more information on how to keep your liver happy and healthy, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

p>

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services. p>